Ni R - Search Results

1

Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.

Zhang S, Shi W, Chen Y, Xu Z, Zhu J, Zhang T, Huang W, Ni R, Lu C, Zhang X. Zhang S, et al. Among authors: ni r. Mol Cell Biochem. 2015 Dec;410(1-2):1-9. doi: 10.1007/s11010-015-2533-9. Epub 2015 Aug 11. Mol Cell Biochem. 2015. PMID: 26260052

2

Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.

Ni W, Chen B, Zhou G, Lu C, Xiao M, Guan C, Zhang Y, He S, Shen A, Ni R. Ni W, et al. Among authors: ni r. J Cell Biochem. 2013 Sep;114(9):2120-30. doi: 10.1002/jcb.24560. J Cell Biochem. 2013. PMID: 23553841

3

High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma.

Liu G, Huang X, Cui X, Zhang J, Wei L, Ni R, Lu C. Liu G, et al. Among authors: ni r. Med Oncol. 2013;30(3):537. doi: 10.1007/s12032-013-0537-4. Epub 2013 May 22. Med Oncol. 2013. PMID: 23696020

4

High CHMP4B expression is associated with accelerated cell proliferation and resistance to doxorubicin in hepatocellular carcinoma.

Hu B, Jiang D, Chen Y, Wei L, Zhang S, Zhao F, Ni R, Lu C, Wan C. Hu B, et al. Among authors: ni r. Tumour Biol. 2015 Apr;36(4):2569-81. doi: 10.1007/s13277-014-2873-1. Epub 2015 Feb 11. Tumour Biol. 2015. PMID: 25874485

5

Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.

Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, Chen B, Shi W. Xu P, et al. Among authors: ni w, ni r. Dig Dis Sci. 2015 Nov;60(11):3351-63. doi: 10.1007/s10620-015-3774-x. Epub 2015 Jun 30. Dig Dis Sci. 2015. PMID: 26123838

6

Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.

Yan X, Zhou H, Zhang T, Xu P, Zhang S, Huang W, Yang L, Gu X, Ni R, Zhang T. Yan X, et al. Among authors: ni r. Tumour Biol. 2015 Dec;36(12):9611-9. doi: 10.1007/s13277-015-3701-y. Epub 2015 Jul 6. Tumour Biol. 2015. PMID: 26142732

7

The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.

Zhang T, Wan C, Shi W, Xu J, Fan H, Zhang S, Lin Z, Ni R, Zhang X. Zhang T, et al. Among authors: ni r. J Mol Histol. 2015 Dec;46(6):485-97. doi: 10.1007/s10735-015-9639-y. Epub 2015 Oct 5. J Mol Histol. 2015. PMID: 26438629

8

Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.

Qiu H, Zhang X, Ni W, Shi W, Fan H, Xu J, Chen Y, Ni R, Tao T. Qiu H, et al. Among authors: ni w, ni r. Dig Dis Sci. 2016 Mar;61(3):795-805. doi: 10.1007/s10620-015-3937-9. Epub 2015 Nov 9. Dig Dis Sci. 2016. PMID: 26553251

9

Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.

Shi W, Huang W, Chen Y, Zhang S, Xu P, Gu X, Fan H, Xu J, Chen Y, Ni R, Lu C, Zhang X. Shi W, et al. Among authors: ni r. Tumour Biol. 2016 Aug;37(8):10447-57. doi: 10.1007/s13277-015-4556-y. Epub 2016 Feb 5. Tumour Biol. 2016. PMID: 26846109

10

Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma.

Liu J, Cui X, Qu L, Hua L, Wu M, Shen Z, Lu C, Ni R. Liu J, et al. Among authors: ni r. Exp Mol Pathol. 2016 Aug;101(1):58-65. doi: 10.1016/j.yexmp.2016.06.003. Epub 2016 Jun 11. Exp Mol Pathol. 2016. PMID: 27302463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

893 results

Search Page

Filters